If PDF does not display, click here to download

1
Evaluate Pharma/World Preview 2019, Outlook to 2024/Evaluate/2019/~// Google Scholar ›
2
Competitiveness of Global and Domestic Pharmaceutical Industry : Focus on Biopharmaceutical Industry/Export and Import Bank of Korea//2017/~/// Google Scholar ›
3
Financial supervisory service Data Analysis, Retrieval and Transfer System/ABLBIO Prospectus//2018/~// Google Scholar ›
4
ABLBIO Securities Report/Financial supervisory service Data Analysis, Retrieval and Transfer System//2018/~/ Google Scholar ›
5
Revitalization Plan for SME Venture Business Investment Finance/Financial Services Commission//2015/~/ Google Scholar ›
6
Financial Services Commission/Improvement of listing system to promote IPOs of innovative companies//2019/~// Google Scholar ›
7
김인호/셀트리온의 코스닥시장 우회상장 사례/Korea Business Review/2010/14(1)/177~196/한국경영학회/ Google Scholar ›
8
Role and task of promotion of venture capital/Jahyun Koo/Korea Development Institute/2017/~/// Google Scholar ›
9
Biopharmaceutical Industry Trend Report/Korea Biomedicine Industry Association//2018/~/ Google Scholar ›
10
Korean Venture Capital Association/Venture Capital Market Brief//2019/~// Google Scholar ›
11
Korea Bio Industry Survey Report as of 2017/Ministry of Trade, Industry and Energy//2018/~/ Google Scholar ›
12
ABLBIO Analysis Report, Korea investor relations service/NICE information service//2018/~/ Google Scholar ›
13
강상구/상장공모(IPO) 시장에서 기존 주주의 투자자금 회수전략: 만도의 구주매출 사례/Korea Business Review/2012/16(4)/141~164/한국경영학회/ Google Scholar ›
14
Korea Bio Industry Survey/Statistics Korea//2015/~/ Google Scholar ›
15
Sunwoo Kim/Current Status and Challenges of Funds Raising by Startup Companies/Entrepreneurship Korea/2017/5/18~20// Google Scholar ›
16
Taegyu Lee/Venture Capital Domestic and International Comparison and Evaluation and Policy Implications/KERI Brief/2017//~// Google Scholar ›
17
모험자본의 보육․육성의 역할과 과제/구자현/한국개발연구원/2017/~/// Google Scholar ›
18
에이비엘바이오 투자설명서/dart.fss.or.kr/금융감독원 전자공시시스템/// Google Scholar ›
19
에이비엘바이오 증권발행실적보고서/dart.fss.or.kr/금융감독원 전자공시시스템/// Google Scholar ›
20
에이비엘바이오 증권신고서/dart.fss.or.kr/금융감독원 전자공시시스템/// Google Scholar ›
21
에이비엘바이오 감사보고서/dart.fss.or.kr/금융감독원 전자공시시스템/// Google Scholar ›
22
중소․벤처기업투자금융활성화방안/금융위원회//2015/~/ Google Scholar ›
23
혁신기업 IPO 촉진을 위한 상장제도개선/금융위원회//2019/~/// Google Scholar ›
24
김선우/창업기업의 자금조달 수단별 현황과 과제/Entrepreneurship Korea/2017/5/18~20// Google Scholar ›
25
에이비엘바이오 기술분석보고서/나이스평가정보/한국IR협의회/2018/~/ Google Scholar ›
26
투자자가 뽑은 차세대 항암제는 ‘이중항체’/www.thebell.co.kr/더벨/2019// Google Scholar ›
27
올해도 기술특례 상장 파란불…‘역대 최대’ 경신할까/www.dt.co.kr/디지털타임스/2019// Google Scholar ›
28
ABL바이오, ‘VEGF-DLL4 항체’ 임상1상 결과 발표/www.biospectator.com/바이오스펙테이터/2019// Google Scholar ›
29
한국바이오협회(2018) 2017년 기준 국내 바이오산업 실태조사 결과 보고서/산업통상자원부///~/ Google Scholar ›
30
벤처캐피탈 국내외 비교 및 평가와 정책적시사점/이태규/KERI Brief/2017/~/ Google Scholar ›
31
에이비엘바이오/에이비엘바이오 IR 자료//2018/~// Google Scholar ›
32
국내바이오산업실태조사/통계청//2015/~/ Google Scholar ›
33
한국거래소 홈페이지/www.krx.co.kr//// Google Scholar ›
34
바이오의약품산업동향 보고서///2018/~/ Google Scholar ›
35
한국벤처캐피탈협회/Venture Capital Market Brief//2019/~// Google Scholar ›
36
세계 의약품 산업 및 국내산업경쟁력 현황 : 바이오의약품 중심/한국수출입은행//2017/~/// Google Scholar ›

A Technology-Based IPO in Korea’s Pharmaceutical Bio-Industry: ABLBio Case